drugset / Trial / NCT00368303

A Local Register Study For Major Depression Of Paroxetine Controlled Release

NCT00368303

Phase 3 Completed 362 enrolled GlaxoSmithKline
RandomizedParallel-groupDouble-blindTreatment

Summary

The study is to investigate the non-inferior efficacy of Paroxetine Controlled Release to Paroxetine Immediate Release, as well as the drug tolerability profile when treated on patients with Major Depression.

Timeline

Start
2006-12
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Paroxetine Small molecule